Stephen R. Walsh

A Bivalent Omicron-Containing Booster Vaccine against Covid-19

Spyros Chalkias, Charles Harper, Keith Vrbicky et al. · New England Journal of Medicine · 2022 · 638 citations · Full text

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

Kayvon Modjarrad, Leyi Lin, Sarah L. George et al. · The Lancet · 2017 · 193 citations · Full text

Vaccination, Vaccine Safety, Vaccinology +7

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)

Lindsey R. Baden, Stephen R. Walsh, Michael S. Seaman et al. · The Journal of Infectious Diseases · 2012 · 168 citations · Full text

Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial

Spyros Chalkias, Frank Eder, Brandon Essink et al. · Nature Medicine · 2022 · 143 citations · Full text

Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial

Boris Jülg, Kathryn E. Stephenson, Kshitij Wagh et al. · Nature Medicine · 2022 · 128 citations · Full text